Colony formation in vitro as a prognostic indicator for primary breast cancer
- PMID: 3035110
- DOI: 10.1200/JCO.1987.5.6.890
Colony formation in vitro as a prognostic indicator for primary breast cancer
Abstract
Cells from some, but not all, tumor biopsy samples form colonies when cultured in semi-solid media. The possibility that colony formation by progenitor cells in these tumors may reflect a more "aggressive" phenotype bearing clinical implications was examined in a series of 61 patients with primary breast cancer. Tumor cells from 32 samples formed colonies in vitro. There was no correlation between colony formation and any of the standard clinical parameters such as tumor size, nodal status, metastatic spread, or hormone receptor levels. Eighteen patients had inflammatory, locally advanced and/or detectable metastatic breast cancer at the time of surgery. Sixteen of these patients have progressed and 15 have died, with no relationship between colony formation and survival. For the 43 remaining patients, 23 had a tissue sample that gave rise to colonies in vitro; 14 of these have relapsed, with a median relapse-free survival (RFS) of 37.6 months, and eight have died with a median survival time of 46.8 months. This is compared with four relapses (median RFS not reached, P = .0043, Peto-Pike), and four deaths (median not reached, P = .1175) in the group without growth of the tumor specimen. These results indicate that colony formation is an independent prognostic parameter for breast cancer, which may be useful for selecting patients who would benefit from more intensive therapy.
Similar articles
-
In vitro clonogenic growth and metastatic potential of human operable breast cancer.Cancer Res. 1989 Oct 1;49(19):5288-93. Cancer Res. 1989. PMID: 2766296
-
Hormone dependency of human breast neoplasms cultured in vitro in the stem cell assay.J Natl Cancer Inst. 1985 Apr;74(4):767-70. J Natl Cancer Inst. 1985. PMID: 2985856
-
Colony forming ability of human breast carcinomas: lack of prognostic significance.Br J Cancer. 1989 Aug;60(2):216-9. doi: 10.1038/bjc.1989.254. Br J Cancer. 1989. PMID: 2765368 Free PMC article.
-
Who should not undergo breast conservation?Breast. 2013 Aug;22 Suppl 2:S110-4. doi: 10.1016/j.breast.2013.07.021. Breast. 2013. PMID: 24074770 Review.
-
Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?Breast Cancer Res Treat. 2010 Jul;122(1):27-34. doi: 10.1007/s10549-010-0917-9. Epub 2010 May 8. Breast Cancer Res Treat. 2010. PMID: 20454925 Review.
Cited by
-
Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells.Antioxidants (Basel). 2020 Jan 12;9(1):68. doi: 10.3390/antiox9010068. Antioxidants (Basel). 2020. PMID: 31940946 Free PMC article.
-
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models.Breast Cancer (Dove Med Press). 2023 Dec 8;15:899-912. doi: 10.2147/BCTT.S434973. eCollection 2023. Breast Cancer (Dove Med Press). 2023. PMID: 38090281 Free PMC article.
-
Isolation and Characterization of Novel Canine Osteosarcoma Cell Lines from Chemotherapy-Naïve Patients.Cells. 2023 Mar 27;12(7):1026. doi: 10.3390/cells12071026. Cells. 2023. PMID: 37048099 Free PMC article.
-
Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer.Oncol Rep. 2017 Nov;38(5):2774-2786. doi: 10.3892/or.2017.5932. Epub 2017 Aug 30. Oncol Rep. 2017. PMID: 28901514 Free PMC article.
-
Redox signalling to nuclear regulatory proteins by reactive oxygen species contributes to oestrogen-induced growth of breast cancer cells.Br J Cancer. 2015 May 12;112(10):1687-702. doi: 10.1038/bjc.2014.586. Br J Cancer. 2015. PMID: 25965299 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical